Symbols

VRTX

Vertex Pharmaceuticals·NASDAQ

--(--)

VRTX Profile

Vertex Pharmaceuticals Incorporated

A company that develops therapies for the treatment of cystic fibrosis

Industry

Biological Technology

Established Date

Listing Date

07/24/1991

Exchange

NASDAQ Stock Exchange

Full-time Employees

6,400

Fiscal Year Ends

12-31

Website

www.vrtx.com

Security Type

Common stock

Office address

50 Northern Avenue, Boston, Massachusetts 02210

Business

Develop and create transformative drugs

Introduction

Incorporated in Massachusetts in 1989, Vertex Pharmaceuticals Incorporated is a global biotechnology company dedicated to scientific innovation to create transformative medicines for individuals with serious diseases, especially in the specialty market. The company has developed approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain. The company continues to innovate and advance next-generation clinical and research projects across a variety of serious diseases, including IgA nephropathy and type 1 diabetes.